Prednisolone absorption in inflammatory bowel disease: correlation with anatomical site and extent
- 31 March 2007
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 1 (5) , 391-399
- https://doi.org/10.1111/j.1365-2036.1987.tb00639.x
Abstract
Prednisolone absorption was studied in 13 normal subjects, eight patients with ulcerative colitis and 21 patients with Crohn's disease, by measuring plasma levels after a single oral dose. Absorption of the drug was delayed in all patient groups. The peak plasma level of the drug was lower in patients with extensive small bowel Crohn's disease. Patients in this category may need higher doses of oral prednisolone than other patients with inflammatory bowel disease.Keywords
This publication has 10 references indexed in Scilit:
- Bioavailability of Prednisolone in Patients with Intestinal Malabsorption: The Importance of Measuring Serum Protein-BindingScandinavian Journal of Gastroenterology, 1983
- Absorption of prednisolone in patients with Crohn's disease.Gut, 1983
- Effect of inflammatory bowel disease on absorption and disposition of prednisoloneDigestive Diseases and Sciences, 1983
- Serum Prednisolone Levels in Crohn’s Disease and Coeliac Disease following Oral Prednisolone AdministrationDigestion, 1981
- Pharmacokinetics of intravenous and oral prednisolone.British Journal of Clinical Pharmacology, 1980
- Prednisolone absorption in acute colitis.Gut, 1980
- Clinical Pharmacokinetics of Prednisone and PrednisoloneClinical Pharmacokinetics, 1979
- Effect of Food on the Bioavailability of PrednisoneThe Journal of Clinical Pharmacology, 1976
- PREDNISONE SIDE-EFFECTS AND SERUM-PROTEIN LEVELSThe Lancet, 1971
- Cortisone in Ulcerative ColitisBMJ, 1955